Tool to help decide diagnosis and treatment in immune disorders
Part of Blood & lymphatic, Bones, joints & muscles, Digestive system, Genetic & congenital, Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This trial tests a tool (a way of collecting health information) to help doctors make better diagnosis, prognosis, and treatment decisions for children with certain immune problems. It also includes healthy children (like relatives) as comparison groups, to see how well the tool works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a child under 18 years old
- Weigh more than 9 kg if you are a patient (more than 6 kg if you are a control/comparison person)
- Have immune-related disease due to a known genetic defect (for patients)
- Get care at Necker Hospital (for patients)
- A parent must be able to sign consent (and forms must be available)
- Avoid certain recent meds: no antibiotics in the past 2 weeks (and no antiviral treatment for HIV/hepatitis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.
This study collects blood and tissue samples from patients with rare immune system diseases that started in childhood, and from their relatives and healthy volunteers. The goal is to build a biocollection for future research to better understand these diseases.
This study looks at immune cells in people with certain autoimmune diseases or immune deficiencies. The goal is to understand how these cells work, which may help improve future treatments.
This study collects blood, tissue, and other samples from people with autoimmune diseases like Crohn's disease, multiple sclerosis, or lupus. Researchers will study your immune cells (T cells) to learn what they are attacking, which could lead to better treatments in the future.
This study collects blood (and sometimes related samples) to learn how genes and the immune system work in people with primary immunodeficiency (PID) or in family members who may not have it. The goal is to improve understanding of rare immune conditions and help guide future care.
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
Hear when a new Autoimmune Cytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.